Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis

References

• LvLHuWRenYWeiXMinimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysisOnco Targets Ther201696751676227826201
   PubMed Web of Science ®Google Scholar
• VisserEFrankenIABrosensLARuurdaJPvan HillegersbergRPrognostic gene expression profiling in esophageal cancer: a systematic reviewOncotarget2017835566557727852047
   PubMedGoogle Scholar
• MannathJRagunathKRole of endoscopy in early oesophageal cancerNat Rev Gastroenterol Hepatol2016131272073027807370
   PubMedGoogle Scholar
• GoodeEFSmythECImmunotherapy for gastroesophageal cancerJ Clin Med201651084
   PubMed Web of Science ®Google Scholar
• MuYZhouCHChenSFEffectiveness and safety of chemotherapy combined with cytokine-induced killer cell/dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: a systematic review and meta-analysisCytotherapy20161891162117727421742
   PubMed Web of Science ®Google Scholar
• ZhouCLLiuDLLiJChemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: a meta-analysisOncotarget2016752865008651027863436
   PubMedGoogle Scholar
• SiYDengZLanGThe safety and immunological effects of rAd5-EBV-LMP2 vaccine in nasopharyngeal carcinoma patients: a phase I clinical trial and two-year follow-upChem Pharm Bull (Tokyo)20166481118112327477649
   PubMed Web of Science ®Google Scholar
• PassalacquaRCaminitiCButiSAdjuvant low-dose interleukin-2 (IL-2) plus interferon-alpha (IFN-alpha) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC)J Immunother201437944044725304727
   PubMedGoogle Scholar
• ZhangTXieJAraiSThe efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysisOncotarget2016745730687307927683031
   PubMedGoogle Scholar
• WeberJSD’AngeloSPMinorDNivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trialLancet Oncol201516437538425795410
   PubMed Web of Science ®Google Scholar
• LiJQinSXuJRandomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctionJ Clin Oncol201634131448145426884585
   PubMed Web of Science ®Google Scholar
• BoyeMWangXSrimuninnimitVFirst-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian never-smoker patients with locally advanced or metastatic nonsquamous non-small-cell lung cancer: quality of life results from a randomized phase III trialClin Lung Cancer201617215016026809984
   PubMed Web of Science ®Google Scholar
• StanculeanuDLDanielaZLazescuABunghezRAnghelRDevelopment of new immunotherapy treatments in different cancer typesJ Med Life20169324024827974927
   PubMedGoogle Scholar
• PeoplesGEGurneyJMHuemanMTClinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patientsJ Clin Oncol200523307536754516157940
   PubMed Web of Science ®Google Scholar
• DudleyMEGrossCASomervilleRPRandomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanomaJ Clin Oncol201331172152215923650429
   PubMed Web of Science ®Google Scholar
• ZhaoZLiaoHJuYEffect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapyJ Tradit Chin Med2016361141826946613
   PubMedGoogle Scholar
• ChiaWKTeoMWangWWAdoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaMol Ther201422113213924297049
   PubMed Web of Science ®Google Scholar
• JäkelCEVogtAGonzalez-CarmonaMASchmidt-WolfIGHClinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumorsJ Immunol Res20142014112
   Google Scholar
• ShiLRZhouQWuJEfficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancerCancer Immunol Immunother201261122251225922674056
   PubMed Web of Science ®Google Scholar
• LiGXZhaoSSZhangXGComparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitroMol Med Rep20151222629263525955083
   PubMed Web of Science ®Google Scholar
• MehtaBASchmidt-WolfIGWeissmanILNegrinRSTwo pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cellsBlood1995869349334997579455
   PubMed Web of Science ®Google Scholar
• ZhuYZhangHLiYEfficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancerCancer Immunol Immunother201362101629163523974720
   PubMed Web of Science ®Google Scholar
• WeiXCYangDDHanXRBioactivity of umbilical cord blood dendritic cells and anti-leukemia effectInt J Clin Exp Med2015810197251973026770637
   PubMed Web of Science ®Google Scholar
• LiHRenXBZhangPAnXMLiuHHaoXS树突状细胞对CIK细 胞中CD4+CD25+ T细胞数量及免疫调节作用的影响 [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells]Zhonghua Yi Xue Za Zhi200585443134313816405818
   PubMedGoogle Scholar
• GaoDQLiCYXieXHAutologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patientsPLoS One201494e9388624699863
   PubMed Web of Science ®Google Scholar
• YanLWuMBaNEfficacy of dendritic cell-cytokine-induced killer immunotherapy plus intensity-modulated radiation therapy in treating elderly patients with esophageal carcinomaGenet Mol Res201514189890525730028
   PubMedGoogle Scholar
• ZhangZWangLPLuoZZEfficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignanciesCytotherapy20151781130113825963952
   PubMed Web of Science ®Google Scholar
• ChangZGXuQXMaLHeLMClinical observation of cytokine induced killer cell intravenous transfusion combined with chemotherapy in treatment of advanced esophageal cancerShandong Med J201353235354
   Google Scholar
• HuYQEffect of herb plus adoptive immunotherapy with cytokine induced killer cells on cellular immunity of patients with advanced esophageal carcinomaJ Bengbu Med Coll201237910621066
   Google Scholar
• LiuGJMeiJZXiaoPLiRJLiMEfficacy of chemotherapy combined with cytokine-induced killer cells in the treatment of advanced esophageal carcinomaJ Zhengzhou Univ2011462169173
   Google Scholar
• QuWFZhangWMDingXYIL-12 induced CIK cells combined with chemotherapy improve immune function and efficacy in patients with esophageal carcinomaShi Jie Hua Ren Xiao Hua Za Zhi2015232845534557
   Google Scholar
• ShuXLiGXZhuXLLiGGanQWangZYAutologous cytokine-induced killer cells combined with chemoradiation in the treatment of locally advanced esophageal carcinoma: a randomized control studyMod Oncol2015231013761380
   Google Scholar
• WangHShuWMaoGHZhangYJShiTLEffect of dendritic cell-cytokine-induced killer cell adoptive immunotherapy combined with chemotherapy on T cell subsets of patients with esophageal cancerContemp Med2014202813
   Google Scholar
• XiXXLvBHYeTChenRXuXEffect of DC-CIK cells’ biotherapy in comprehensive therapy of esophagus cancer: a randomized controlled trialChin J Clin Thorac Cardiovasc Surg2015228765769
   Google Scholar
• XuBLGaoQLFanRHLiuXGuoJDZhangCJClinical effects on chemotherapy combined with CIK for patients with advanced oesophageal carcinomaHenan Med Res2010193315320
   Google Scholar
• YangBLiWSunXAChenYMThe clinical efficacy of endoscopic implantation with chemotherapeutic slow-release combined with DC-CIK immune cells infusion for patients with obstructive esophageal cancersChina J Endoscopy2015215483486
   Google Scholar
• ZhuHPZhangQAAnalysis of the effect of injection in treatment of advanced esophageal cancer paclitaxel cisplatin regimen combined with autologous CIK cellsChin J Clin Oncol Rehabil2014217837839
   Google Scholar
• ZengXZhangYKwongJSThe methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic reviewJ Evid Based Med20158121025594108
   PubMedGoogle Scholar
• HanRXLiuXPanPJiaYJYuJCEffectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysisPLoS One201499e10895825268709
   PubMed Web of Science ®Google Scholar
• JacksonDWhiteIRRileyRDQuantifying the impact of between-study heterogeneity in multivariate meta-analysesStat Med201231293805382022763950
   PubMed Web of Science ®Google Scholar
• WangZXCaoJXWangMAdoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysisCytotherapy201416793494524794183
   PubMed Web of Science ®Google Scholar
• MilasieneVStratilatovasENorkieneVThe importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patientsMedicina (Kaunas)200743754855417768369
   PubMedGoogle Scholar
• ChoMYJohYGKimNRT-lymphocyte subsets in patients with AJCC stage III gastric cancer during postoperative adjuvant chemotherapy. American Joint Committee on CancerScand J Surg200291217217712164518
   PubMedGoogle Scholar
• TaoQWangHZhaiZTargeting regulatory T cells in cytokine-induced killer cell cultures (Review)Biomed Rep20142331732024748966
   PubMedGoogle Scholar
• MuYWangWHXieJPZhangYXYangYPZhouCHEfficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II studyOnco Targets Ther201694617462727524915
   PubMed Web of Science ®Google Scholar
• OliosoPGiancolaRDi RitiMContentoAAccorsiPIaconeAImmunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trialHematol Oncol200927313013919294626
   PubMed Web of Science ®Google Scholar
• LeeJHLimYSLimYSAdjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinomaGastroenterology201514871383.e61391.e625747273
   PubMedGoogle Scholar
• IntronaMPievaniABorleriGFeasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantationBiol Blood Marrow Transplant201016111603160720685246
   PubMed Web of Science ®Google Scholar
• MaYZhangZTangLCytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysisCytotherapy201214448349322277010
   PubMed Web of Science ®Google Scholar
• ZhangTCaoLXieJEfficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysisOncotarget2015632339613397126376680
   PubMedGoogle Scholar
• KatzSCBurgaRAMcCormackEPhase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified T-cell therapy for CEA+ liver metastasesClin Cancer Res201521143149315925850950
   PubMed Web of Science ®Google Scholar